drugset / Trial / NCT00485433

Dose-ranging Study for Postoperative Analgesia in Subjects Undergoing Primary Unilateral Inguinal Hernia Repair

NCT00485433

Phase 2 Completed 98 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupTriple-blindOther

Summary

The purpose of this study is to evaluate three dose levels of SKY0402 compared with 105 mg of bupivacaine HCl.

Timeline

Start
2007-06
Primary completion
2007-12
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 105 mg Other
Subject SKY0402 Unknown Other

Indications

No indication recorded.